Failure of ascorbic acid to inhibit growth of transplantable and dimethylbenzanthracene induced rat mammary tumors
- 1 October 1982
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 17 (1) , 67-73
- https://doi.org/10.1016/0304-3835(82)90110-0
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Inhibition of benzo(a)pyrene Carcinogenesis in rats with vitamin CZeitschrift für Krebsforschung und Klinische Onkologie, 1980
- The orthomolecular treatment of cancerChemico-Biological Interactions, 1975
- Failure of Ascorbic Acid to Inhibit Fanft-Induced Bladder CancerJournal of Urology, 1975
- The orthomolecular treatment of cancer II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancerChemico-Biological Interactions, 1974
- The orthomolecular treatment of cancer I. The role of ascorbic acid in host resistanceChemico-Biological Interactions, 1974
- Leucocyte ascorbic acid and urinary hydroxyproline levels in patients bearing breast cancer with skeletal metastasesPublished by Elsevier ,1974
- Ascorbic Acid Deficiency in Malignant Diseases: A Clinical and Biochemical StudyBritish Journal of Cancer, 1974
- Ascorbic Acid and the GlycosaminoglycansOncology, 1973
- ASCORBIC ACID, CELL PROLIFERATION, AND CANCERThe Lancet, 1972
- Antitumor potency of ascorbic, dehydroascorbic or 2, 3-dike-togulonic acid and their action on deoxyribonucleic acidZeitschrift für Krebsforschung und Klinische Onkologie, 1971